- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Gabapentin market will register a 1.9% CAGR in terms of revenue, the global market size will reach $ 1565.9 million by 2025, from $ 1454.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gabapentin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin market by type, application, key manufacturers and key regions and countries.
This study considers the Gabapentin value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Capsule
Tablet
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Intas
Assertio Therapeutics
Mylan
Arbor Pharma
TEVA
Sun Pharmaceutical
Novartis
Aurobindo Pharma
Apotex
Jiangsu Hengrui
Sailike
Amneal
Alkem
Glenmark
Jiangsu Enhua
Marksans Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Gabapentin consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Gabapentin market by identifying its various subsegments.
Focuses on the key global Gabapentin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gabapentin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Gabapentin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gabapentin Consumption 2015-2025
2.1.2 Gabapentin Consumption CAGR by Region
2.2 Gabapentin Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Gabapentin Consumption by Type
2.3.1 Global Gabapentin Consumption Market Share by Type (2015-2020)
2.3.2 Global Gabapentin Revenue and Market Share by Type (2015-2020)
2.3.3 Global Gabapentin Sale Price by Type (2015-2020)
2.4 Gabapentin Segment by Application
2.4.1 Epilepsy
2.4.2 Neuropathic Pain
2.4.3 Restless Legs Syndrome
2.4.4 Others
2.5 Gabapentin Consumption by Application
2.5.1 Global Gabapentin Consumption Market Share by Type (2015-2020)
2.5.2 Global Gabapentin Value and Market Share by Type (2015-2020)
2.5.3 Global Gabapentin Sale Price by Type (2015-2020)
3 Global Gabapentin by Company
3.1 Global Gabapentin Sales Market Share by Company
3.1.1 Global Gabapentin Sales by Company (2018-2020)
3.1.2 Global Gabapentin Sales Market Share by Company (2018-2020)
3.2 Global Gabapentin Revenue Market Share by Company
3.2.1 Global Gabapentin Revenue by Company (2018-2020)
3.2.2 Global Gabapentin Revenue Market Share by Company (2018-2020)
3.3 Global Gabapentin Sale Price by Company
3.4 Global Gabapentin Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Gabapentin Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Gabapentin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Gabapentin by Regions
4.1 Gabapentin by Regions
4.2 Americas Gabapentin Consumption Growth
4.3 APAC Gabapentin Consumption Growth
4.4 Europe Gabapentin Consumption Growth
4.5 Middle East & Africa Gabapentin Consumption Growth
5 Americas
5.1 Americas Gabapentin Consumption by Countries
5.1.1 Americas Gabapentin Consumption by Countries (2015-2020)
5.1.2 Americas Gabapentin Value by Countries (2015-2020)
5.2 Americas Gabapentin Consumption by Type
5.3 Americas Gabapentin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Gabapentin Consumption by Regions
6.1.1 APAC Gabapentin Consumption by Regions (2015-2020)
6.1.2 APAC Gabapentin Value by Regions (2015-2020)
6.2 APAC Gabapentin Consumption by Type
6.3 APAC Gabapentin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Gabapentin by Countries
7.1.1 Europe Gabapentin Consumption by Countries (2015-2020)
7.1.2 Europe Gabapentin Value by Countries (2015-2020)
7.2 Europe Gabapentin Consumption by Type
7.3 Europe Gabapentin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Gabapentin by Countries
8.1.1 Middle East & Africa Gabapentin Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Gabapentin Value by Countries (2015-2020)
8.2 Middle East & Africa Gabapentin Consumption by Type
8.3 Middle East & Africa Gabapentin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Gabapentin Distributors
10.3 Gabapentin Customer
11 Global Gabapentin Market Forecast
11.1 Global Gabapentin Consumption Forecast (2021-2025)
11.2 Global Gabapentin Forecast by Regions
11.2.1 Global Gabapentin Forecast by Regions (2021-2025)
11.2.2 Global Gabapentin Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Gabapentin Forecast by Type
11.8 Global Gabapentin Forecast by Application
12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Gabapentin Product Offered
12.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Intas
12.2.1 Company Information
12.2.2 Gabapentin Product Offered
12.2.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Intas Latest Developments
12.3 Assertio Therapeutics
12.3.1 Company Information
12.3.2 Gabapentin Product Offered
12.3.3 Assertio Therapeutics Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Assertio Therapeutics Latest Developments
12.4 Mylan
12.4.1 Company Information
12.4.2 Gabapentin Product Offered
12.4.3 Mylan Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Mylan Latest Developments
12.5 Arbor Pharma
12.5.1 Company Information
12.5.2 Gabapentin Product Offered
12.5.3 Arbor Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Arbor Pharma Latest Developments
12.6 TEVA
12.6.1 Company Information
12.6.2 Gabapentin Product Offered
12.6.3 TEVA Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 TEVA Latest Developments
12.7 Sun Pharmaceutical
12.7.1 Company Information
12.7.2 Gabapentin Product Offered
12.7.3 Sun Pharmaceutical Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Sun Pharmaceutical Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Gabapentin Product Offered
12.8.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 Aurobindo Pharma
12.9.1 Company Information
12.9.2 Gabapentin Product Offered
12.9.3 Aurobindo Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Aurobindo Pharma Latest Developments
12.10 Apotex
12.10.1 Company Information
12.10.2 Gabapentin Product Offered
12.10.3 Apotex Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Apotex Latest Developments
12.11 Jiangsu Hengrui
12.11.1 Company Information
12.11.2 Gabapentin Product Offered
12.11.3 Jiangsu Hengrui Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Jiangsu Hengrui Latest Developments
12.12 Sailike
12.12.1 Company Information
12.12.2 Gabapentin Product Offered
12.12.3 Sailike Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Sailike Latest Developments
12.13 Amneal
12.13.1 Company Information
12.13.2 Gabapentin Product Offered
12.13.3 Amneal Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Amneal Latest Developments
12.14 Alkem
12.14.1 Company Information
12.14.2 Gabapentin Product Offered
12.14.3 Alkem Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Alkem Latest Developments
12.15 Glenmark
12.15.1 Company Information
12.15.2 Gabapentin Product Offered
12.15.3 Glenmark Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Glenmark Latest Developments
12.16 Jiangsu Enhua
12.16.1 Company Information
12.16.2 Gabapentin Product Offered
12.16.3 Jiangsu Enhua Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Jiangsu Enhua Latest Developments
12.17 Marksans Pharma
12.17.1 Company Information
12.17.2 Gabapentin Product Offered
12.17.3 Marksans Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Marksans Pharma Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Gabapentin Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Capsule
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
